- /
- Supported exchanges
- / US
- / LH.NYSE
Laboratory Corporation of America Holdings (LH NYSE) stock market data APIs
Laboratory Corporation of America Holdings Financial Data Overview
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Laboratory Corporation of America Holdings (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Laboratory Corporation of America Holdings data using free add-ons & libraries
Get Laboratory Corporation of America Holdings Fundamental Data
Laboratory Corporation of America Holdings Fundamental data includes:
- Net Revenue: 14 348 M
- EBITDA: 2 320 M
- Earnings Per Share: 12
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Laboratory Corporation of America Holdings Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-07-30
- EPS/Forecast: 4.79
Get Laboratory Corporation of America Holdings End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Laboratory Corporation of America Holdings News
New
CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs
CVS Health Corporation CVS reported second-quarter 2026 adjusted earnings per share (EPS) of $2.58 per share, up 42.5% year over year. The figure beat the Zacks Consensus Estimate by 37.97%. Revenues...
HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs
Henry Schein, Inc. HSIC reported second-quarter 2026 adjusted earnings of $1.27 per share, up 15.5% year over year. The bottom line surpassed the Zacks Consensus Estimate by 4.1%. Net sales rose 6.7...
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib) BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global...
Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates
Quest Diagnostics Incorporated DGX raised its 2026 revenue and adjusted earnings guidance after second-quarter results topped expectations. The increase reflects faster testing demand across physician...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.